- Previous Close
20.63 - Open
20.22 - Bid 19.64 x --
- Ask 22.17 x 1200
- Day's Range
19.93 - 21.50 - 52 Week Range
4.80 - 35.96 - Volume
42,106 - Avg. Volume
149,011 - Market Cap (intraday)
346.228M - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
-- - EPS (TTM)
-101.92 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
19.00
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
www.claritev.com2,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CTEV
View MorePerformance Overview: CTEV
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTEV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTEV
View MoreValuation Measures
Market Cap
345.06M
Enterprise Value
4.87B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.36
Price/Book (mrq)
4.11
Enterprise Value/Revenue
5.23
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-176.85%
Return on Assets (ttm)
1.02%
Return on Equity (ttm)
-183.57%
Revenue (ttm)
930.62M
Net Income Avi to Common (ttm)
-1.65B
Diluted EPS (ttm)
-101.92
Balance Sheet and Cash Flow
Total Cash (mrq)
16.85M
Total Debt/Equity (mrq)
5,412.79%
Levered Free Cash Flow (ttm)
219.68M